BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38336628)

  • 21. Reliability of Pro-adrenomedullin and Interleukin 1β in Predicting Severity of Community-Acquired Pneumonia in Pediatric Patients.
    Korkmaz MF; Güzel A; Açıkgöz M; Okuyucu A; Alaçam H
    Ann Clin Lab Sci; 2018 Jan; 48(1):81-89. PubMed ID: 29531001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioactive adrenomedullin (bio-ADM) is associated with endothelial dysfunction in infants and children with complex congenital heart disease undergoing open-heart surgery on cardiopulmonary bypass.
    Schaefer M; Stein A; Ruf B; Balling G; Palm J; Simmelbauer A; Cleuziou J; Sander M; Auer J; Borgmann K; Struck J; Hartmann O; Schulte J; Hörer J; Tassani-Prell P; Ewert P; Holdenrieder S; Wolf CM
    Clin Chem Lab Med; 2024 Feb; 62(3):551-561. PubMed ID: 37870269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients.
    Dépret F; Amzallag J; Pollina A; Fayolle-Pivot L; Coutrot M; Chaussard M; Santos K; Hartmann O; Jully M; Fratani A; Oueslati H; Cupaciu A; Benyamina M; Guillemet L; Deniau B; Mebazaa A; Gayat E; Farny B; Textoris J; Legrand M;
    Crit Care; 2020 Apr; 24(1):168. PubMed ID: 32321571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients.
    de Almeida DC; Franco MDCP; Dos Santos DRP; Santos MC; Maltoni IS; Mascotte F; de Souza AA; Pietrobom PM; Medeiros EA; Ferreira PRA; Machado FR; Goes MA
    PLoS One; 2021; 16(5):e0251048. PubMed ID: 34033655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19.
    Roedl K; Jarczak D; Fischer M; Haddad M; Boenisch O; de Heer G; Burdelski C; Frings D; Sensen B; Karakas M; Kluge S; Nierhaus A
    Biomarkers; 2021 Jul; 26(5):417-424. PubMed ID: 33754916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum chemokine IL-8 acts as a biomarker for identifying COVID-19-associated persistent severe acute kidney injury.
    He Z; Liu JJ; Ma SL
    Ren Fail; 2024 Dec; 46(1):2311316. PubMed ID: 38305217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value for Mortality of Plasma Bioactive Adrenomedullin in Patients with Pulmonary Arterial Hypertension: A Sub Analysis of the Biomarker Study in the COHARD-PH Registry.
    Hartopo AB; Anggrahini DW; Dinarti LK; Schäfer AK; Bergmann A; Fachiroh J; Somma SD
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Kidney Injury Can Predict In-Hospital Mortality in Elderly Patients with COVID-19 in the ICU: A Single-Center Study.
    Li Q; Zhang T; Li F; Mao Z; Kang H; Tao L; Zhou F; Cai Y
    Clin Interv Aging; 2020; 15():2095-2107. PubMed ID: 33204075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.
    Xie Y; Ankawi G; Yang B; Garzotto F; Passannante A; Breglia A; Digvijay K; Ferrari F; Brendolan A; Raffaele B; Giavarina D; Gregori D; Ronco C
    Kidney Int; 2019 Jun; 95(6):1486-1493. PubMed ID: 30982674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19.
    Vogel MJ; Mustroph J; Staudner ST; Leininger SB; Hubauer U; Wallner S; Meindl C; Hanses F; Zimmermann M; Maier LS; Jungbauer CG; Hupf J
    J Nephrol; 2021 Aug; 34(4):1007-1018. PubMed ID: 34110585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute kidney injury associated to COVID-19 leads to a strong unbalance of circulant immune mediators.
    Medeiros T; Guimarães GMC; Carvalho FR; Alves LS; Faustino R; Campi-Azevedo AC; Peruhype-Magalhães V; Teixeira-Carvalho A; de Souza Gomes M; Rodrigues do Amaral L; Martins-Filho OA; Lugon JR; Almeida JR; Silva AA
    Cytokine; 2022 Sep; 157():155974. PubMed ID: 35907365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury.
    Ren H; Zhou X; Dai D; Liu X; Wang L; Zhou Y; Luo X; Cai Q
    BMC Nephrol; 2015 Aug; 16():142. PubMed ID: 26283194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial peptides and other potential biomarkers of critical illness in SARS-CoV-2 patients with acute kidney injury. AMPAKI-CoV study.
    Theotonio Dos Santos LF; Barbeiro HV; Barbeiro DF; de Souza HP; Pinheiro da Silva F
    Physiol Rep; 2024 Feb; 12(3):e15945. PubMed ID: 38328863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit.
    Doi K; Noiri E; Nangaku M; Yahagi N; Jayakumar C; Ramesh G
    Nephrol Dial Transplant; 2014 Jan; 29(1):73-80. PubMed ID: 24166457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial.
    Takagi K; Levy B; Kimmoun A; Miró Ò; Duarte K; Asakage A; Blet A; Deniau B; Schulte J; Hartmann O; Cotter G; Davison BA; Gayat E; Mebazaa A
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.
    Doher MP; Torres de Carvalho FR; Scherer PF; Matsui TN; Ammirati AL; Caldin da Silva B; Barbeiro BG; Carneiro FD; Corrêa TD; Ferraz LJR; Dos Santos BFC; Pereira VG; Batista MC; Monte JCM; Santos OFP; Bellomo R; Serpa Neto A; Durão MS
    Blood Purif; 2021; 50(4-5):520-530. PubMed ID: 33341806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologically Active Adrenomedullin (bio-ADM) is of Potential Value in Identifying Congestion and Selecting Patients for Neurohormonal Blockade in Acute Dyspnea.
    Simonavičius J; Mikalauskas A; Čerlinskaitė K; Gayat E; Juknevičius V; Palevičiūtė E; Alitoit-Marrote I; Kablučko D; Bagdonaitė L; Balčiūnas M; Vaičiulienė D; Jonauskienė I; Motiejūnaitė J; Stašaitis K; Kukulskis A; Damalakas Š; Šimbelytė T; Taparauskaitė N; Pukanasienė G; Laucevičius A; Kavoliūnienė A; Mebazaa A; Čelutkienė J;
    Am J Med; 2022 Jul; 135(7):e165-e181. PubMed ID: 35245495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury.
    Ng JH; Hirsch JS; Hazzan A; Wanchoo R; Shah HH; Malieckal DA; Ross DW; Sharma P; Sakhiya V; Fishbane S; Jhaveri KD;
    Am J Kidney Dis; 2021 Feb; 77(2):204-215.e1. PubMed ID: 32961245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The level of the biomarkers at the time of nephrology consultation might predict the prognosis of acute kidney injury in hospitalized patients.
    Renhua L; Miaolin C; Junlin W; Qingwei W; Xiaoping X; Huili D; Weiming Z; Zhaohui N; Jiaqi Q; Yan Y
    Blood Purif; 2014; 38(2):89-95. PubMed ID: 25342236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
    Wainstein M; MacDonald S; Fryer D; Young K; Balan V; Begum H; Burrell A; Citarella BW; Cobb JP; Kelly S; Kennon K; Lee J; Merson L; Murthy S; Nichol A; Semple MG; Strudwick S; Webb SA; Rossignol P; Claure-Del Granado R; Shrapnel S;
    PLoS Med; 2022 Apr; 19(4):e1003969. PubMed ID: 35442972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.